Double stranded RNA‑dependent protein kinase promotes the tumorigenic phenotype in HepG2 hepatocellular carcinoma 
cells by activating STAT3

Wang,Xun; Dong,Jia‑Hong; Zhang,Wen‑Zhi; Leng,Jian‑Jun; Cai,Shou‑Wang; Chen,Ming‑Yi; Yang,Xuerui

doi:10.3892/ol.2014.2560

December-2014 Volume 8 Issue 6

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

December-2014 Volume 8 Issue 6

Full Size Image

Article

Double stranded RNA‑dependent protein kinase promotes the tumorigenic phenotype in HepG2 hepatocellular carcinoma cells by activating STAT3

Authors:
- Xun Wang
- Jia‑Hong Dong
- Wen‑Zhi Zhang
- Jian‑Jun Leng
- Shou‑Wang Cai
- Ming‑Yi Chen
- Xuerui Yang
View Affiliations / Copyright

Affiliations: Department of Hepatobiliary Surgery, The General Hospital of Chinese People's Liberation Army, Beijing 100853, P.R. China, MOE Key Laboratory of Bioinformatics, Tsinghua‑Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing 100084, P.R. China
Pages: 2762-2768
|
Published online on: September 24, 2014

https://doi.org/10.3892/ol.2014.2560
Expand metrics +

Abstract

Previously known as a first‑response protein upon viral infection and other stress signals, double‑stranded RNA‑dependent protein kinase (PKR, also termed EIF2AK2) has been found to be differentially expressed in multiple types of tumor, including hepatocellular carcinoma, suggesting that PKR may be involved in tumor initiation and development. However, whether and how PKR promotes or suppresses the development of hepatocellular carcinoma remains controversial. In the present study, PKR expression was investigated using qPCR and western blot analysis, which revealed that PKR expression was upregulated in liver tumor tissues, when compared to that of adjacent normal tissues, which were obtained from four primary liver cancer patients. Furthermore, in vitro cellular assays revealed that PKR exerts a key role in maintaining the proliferation and migration of HepG2 human hepatocellular carcinoma cells. Mouse models with xenograft transplantations also confirmed a tumorigenic role of PKR in HepG2 cells. Furthermore, a transcription factor, signal transducer and activator of transcription 3 (STAT3), was revealed to mediate the tumor‑promoting function of PKR in HepG2 cells, as shown by in vitro cellular proliferation and migration assays. In conclusion, the results suggested a tumorigenic role of PKR in liver cancer and a detailed mechanism involving an oncogenic transcription factor, STAT3, is described. Therefore, PKR may present a potential novel therapeutic target for the treatment of liver cancer.

View Figures

View References

1	Barber GN: The dsRNA-dependent protein kinase, PKR and cell death. Cell Death Differ. 12:563–570. 2005.
2	Zhang F, Romano PR, Nagamura-Inoue T, et al: Binding of double-stranded RNA to protein kinase PKR is required for dimerization and promotes critical autophosphorylation events in the activation loop. J Biol Chem. 276:24946–24958. 2001.
3	Taylor SS, Haste NM and Ghosh G: PKR and eIF2alpha: integration of kinase dimerization, activation, and substrate docking. Cell. 122:823–825. 2005.
4	Williams BR: Signal integration via PKR. Sci STKE. 2001:re22001.
5	Stark GR, Kerr IM, Williams BR, Silverman RH and Schreiber RD: How cells respond to interferons. Annu Rev Biochem. 67:227–264. 1998.
6	Koromilas AE, Roy S, Barber GN, Katze MG and Sonenberg N: Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science. 257:1685–1689. 1992.
7	Meurs EF, Galabru J, Barber GN, Katze MG and Hovanessian AG: Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA. 90:232–236. 1993.
8	Roh V, Laemmle A, Von Holzen U, et al: Dual induction of PKR with E2F-1 and IFN-alpha to enhance gene therapy against hepatocellular carcinoma. Cancer Gene Ther. 15:636–644. 2008.
9	Hiasa Y, Kamegaya Y, Nuriya H, et al: Protein kinase R is increased and is functional in hepatitis C virus-related hepatocellular carcinoma. Am J Gastroenterol. 98:2528–2534. 2003.
10	Delhem N, Sabile A, Gajardo R, et al: Activation of the interferon-inducible protein kinase PKR by hepatocellular carcinoma derived-hepatitis C virus core protein. Oncogene. 20:5836–5845. 2001.
11	Mohamed AA, Nada OH and El Desouky MA: Implication of protein kinase R gene quantification in hepatitis C virus genotype 4 induced hepatocarcinogenesis. Diagn Pathol. 7:1032012.
12	Kim SH, Forman AP, Mathews MB and Gunnery S: Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR. Oncogene. 19:3086–3094. 2000.
13	Kim SH, Gunnery S, Choe JK and Mathews MB: Neoplastic progression in melanoma and colon cancer is associated with increased expression and activity of the interferon-inducible protein kinase, PKR. Oncogene. 21:8741–8748. 2002.
14	Delgado André N and De Lucca FL: Knockdown of PKR expression by RNAi reduces pulmonary metastatic potential of B16-F10 melanoma cells in mice: Possible role of NF-kappaB. Cancer Lett. 258:118–125. 2007.
15	Donzé O, Deng J, Curran J, et al: The protein kinase PKR: a molecular clock that sequentially activates survival and death programs. EMBO J. 23:564–571. 2004.
16	Yang X and Chan C: Repression of PKR mediates palmitate-induced apoptosis in HepG2 cells through regulation of Bcl-2. Cell Res. 19:469–486. 2009.
17	Kumar A, Yang YL, Flati V, et al: Deficient cytokine signaling in mouse embryo fibroblasts with a targeted deletion in the PKR gene: role of IRF-1 and NF-kappaB. EMBO J. 16:406–416. 1997.
18	Cuddihy AR, Li S, Tam NW, et al: Double-stranded-RNA-activated protein kinase PKR enhances transcriptional activation by tumor suppressor p53. Mol Cell Biol. 19:2475–2484. 1999.
19	Deb A, Zamanian-Daryoush M, Xu Z, Kadereit S and Williams BR: Protein kinase PKR is required for platelet-derived growth factor signaling of c-fos gene expression via Erks and Stat3. EMBO J. 20:2487–2496. 2001.
20	Wang S, Raven JF, Baltzis D, et al: The catalytic activity of the eukaryotic initiation factor-2alpha kinase PKR is required to negatively regulate Stat1 and Stat3 via activation of the T-cell protein-tyrosine phosphatase. J Biol Chem. 281:9439–9449. 2006.
21	Calvisi DF, Ladu S, Gorden A, et al: Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology. 130:1117–1128. 2006.
22	He G, Yu GY, Temkin V, et al: Hepatocyte IKKbeta/NF-kappaB inhibits tumor promotion and progression by preventing oxidative stress-driven STAT3 activation. Cancer Cell. 17:286–297. 2010.
23	Carro MS, Lim WK, Alvarez MJ, et al: The transcriptional network for mesenchymal transformation of brain tumours. Nature. 463:318–325. 2010.
24	Maeda S, Kamata H, Luo JL, Leffert H and Karin M: IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell. 121:977–990. 2005.
25	Maeda S, Hikiba Y, Sakamoto K, et al: Ikappa B kinasebeta/nuclear factor-kappaB activation controls the development of liver metastasis by way of interleukin-6 expression. Hepatology. 50:1851–1860. 2009.
26	He G and Karin M: NF-kappaB and STAT3 - key players in liver inflammation and cancer. Cell Res. 21:159–168. 2011.
27	Papadakis AI, Paraskeva E, Peidis P, et al: eIF2α Kinase PKR Modulates the Hypoxic Response by Stat3-Dependent Transcriptional Suppression of HIF-1α. Cancer Res. 70:7820–7829. 2010.
28	Proud CG: PKR: a new name and new roles. Trends Biochem Sci. 20:241–246. 1995.
29	Kumar A, Haque J, Lacoste J, Hiscott J and Williams BR: Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc Natl Acad Sci USA. 91:6288–6292. 1994.
30	Gil J, Alcamí J and Esteban M: Activation of NF-kappa B by the dsRNA-dependent protein kinase, PKR involves the I kappa B kinase complex. Oncogene. 19:1369–1378. 2000.
31	Zhou HR, Lau AS and Pestka JJ: Role of double-stranded RNA-activated protein kinase R (PKR) in deoxynivalenol-induced ribotoxic stress response. Toxicol Sci. 74:335–344. 2003.
32	Xu Z and Williams BR: The B56alpha regulatory subunit of protein phosphatase 2A is a target for regulation by double-stranded RNA-dependent protein kinase PKR. Mol Cell Biol. 20:5285–5299. 2000.
33	Donzé O, Jagus R, Koromilas AE, Hershey JW and Sonenberg N: Abrogation of translation initiation factor eIF-2 phosphorylation causes malignant transformation of NIH 3T3 cells. EMBO J. 14:3828–3834. 1995.
34	Watanabe T, Hiasa Y, Tokumoto Y, et al: Protein kinase R modulates c-Fos and c-Jun signaling to promote proliferation of hepatocellular carcinoma with hepatitis C virus infection. PLoS One. 8:e677502013.